Company intelligence / Profile preview
BioVie
Carson City, Nevada, USAbioviepharma.com ↗
- Ownership
- Public · BIVI
- Employees
- ~20
- Development stage
- Phase 2
01
Overview
BioVie is a clinical-stage biopharmaceutical company developing small molecule therapies targeting neurodegenerative diseases and advanced liver conditions. Its lead candidate, bezisterim (NE3107), has shown promise in reducing inflammation and improving insulin sensitivity in early studies. The company recently initiated a fully funded Phase II trial in Parkinson's disease with topline data expected late 2025 or early 2026. A once-daily formulation of NE3107 will be used in an upcoming Alzheimer's phase III trial. For refractory ascites due to liver cirrhosis, BIV201 demonstrated >50% reduction of fluid buildup among completers; the program awaits partnership funding before advancing to phase III.[5][6][8]
- Therapeutic areas
- GastroenterologyNeurology
- Modalities
- Small molecules (notably NE3107/bezisterim)[3][5][6]Peptide analogs (BIV201/terlipressin acetate)[3][4]
- Industry
- Biotech
02
Drug pipeline
11 assets10 more assets in the full pipeline.
03
Partnerships
Supported by The Michael J. Fox Foundation, Davis Phinney Foundation, and The Parkinson’s Foundation for the SUNRISE-PD trial; seeking partners especially for the BIV201 program.[6]
04
Financials
- Market cap
- $10.5M
- Total revenue
- $0
- Enterprise value
- $1.8M
Beyond the preview
Go deeper on BioVie.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioVie.